Catherine Coste
Director/Board Member at BIOMERICA, INC.
Net worth: 29 564 $ as of 2024-04-29
Profile
Catherine Havlik Coste is an Independent Director at Biomerica, Inc., Minerva Surgical, Inc., and Renalytix Plc.
She previously worked as a Senior Partner at Deloitte & Touche LLP from 1988 to 2020.
She obtained an undergraduate degree from The California State University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BIOMERICA, INC.
0.26% | 2023-12-12 | 43,790 ( 0.26% ) | 29 558 $ | 2024-04-29 |
MINERVA SURGICAL, INC.
0.07% | 2023-03-30 | 5,940 ( 0.07% ) | 6 $ | 2024-04-29 |
Catherine Coste active positions
Companies | Position | Start |
---|---|---|
BIOMERICA, INC. | Director/Board Member | 2020-09-02 |
MINERVA SURGICAL, INC. | Director/Board Member | 2021-01-31 |
RENALYTIX PLC | Director/Board Member | 2023-06-29 |
Former positions of Catherine Coste
Companies | Position | End |
---|---|---|
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 2020-08-31 |
Training of Catherine Coste
The California State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
BIOMERICA, INC. | Health Technology |
MINERVA SURGICAL, INC. | Health Technology |
RENALYTIX PLC | Technology Services |
Private companies | 1 |
---|---|
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Catherine Coste